Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R B Green

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|May 24, 2017
Charles Henry James SwanJonathan R B Green
Clinical Therapeutics|August 30, 2003
A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitisAnan S Raghunath, Jonathan R B Green, Steven J Edwards
European Journal of Gastroenterology & Hepatology|August 13, 2002
Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 monthsNicholas J Talley, Thomas L Venables, Jonathan R B Green, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|May 24, 2017
Charles Henry James SwanJonathan R B Green
Clinical Therapeutics|August 30, 2003
A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitisAnan S Raghunath, Jonathan R B Green, Steven J Edwards
European Journal of Gastroenterology & Hepatology|August 13, 2002
Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 monthsNicholas J Talley, Thomas L Venables, Jonathan R B Green, et al.
Pageof 1